Top 50 Biotech VC (Venture Capital) Funds in Finland in January 2026
A list of 50 VC (Venture Capital) funds that invest in Biotech startups based in Finland. We rank investors based on the number of investments they made in Biotech companies from Finland. We update this investor list every month.Top 50 Biotech VC (Venture Capital) Funds in Finland in January 2026
| Investor | Biotech Finland investments |
|---|---|
| Business Finland | 10 |
| Tesi | 9 |
| Lifeline Ventures | 9 |
| Voima Ventures | 9 |
| Finnvera Venture Capital | 8 |
| Butterfly Ventures | 5 |
| Springvest | 5 |
| Icebreaker.vc | 4 |
| Stephen Industries | 3 |
| Nordic Foodtech VC | 3 |
| Innovestor | 3 |
| EQT Life Sciences | 2 |
| Finnish Climate Fund | 2 |
| Sofinnova Partners | 2 |
| Inventure | 2 |
| VTT Ventures | 2 |
| Pontos Group | 2 |
| Sitra | 2 |
| Fazer | 2 |
| European Investment Bank | 2 |
| HealthCap | 2 |
| Nordic Science Investments | 2 |
| Zhejiang Huahai Pharmaceutical | 1 |
| Emerald Technology Ventures | 1 |
| Thames Trust | 1 |
| Valve Ventures | 1 |
| XR Invest | 1 |
| Illusian Founder Office | 1 |
| Broadview Ventures | 1 |
| Takoa Invest | 1 |
| Nordea | 1 |
| Stockholm Techstars Accelerator | 1 |
| Wave Ventures | 1 |
| Eqvitec | 1 |
| Valio | 1 |
| MTIP AG | 1 |
| Aqua Spark | 1 |
| Advent Life Sciences | 1 |
| Horizon 2020 | 1 |
| Ananda Impact Ventures | 1 |
| H&M Group Ventures | 1 |
| Keksintösäätiö | 1 |
| Visionplus | 1 |
| Novartis Venture Fund | 1 |
| Tekes Venture Capital | 1 |
| Unifund | 1 |
| HTGF (High-Tech Gruenderfonds) | 1 |
| Cor Group | 1 |
| Athensmed | 1 |
| K5 Global | 1 |
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more
Investment focus
- Software, SaaS, Biotechnology
- Seed, Grant, Funding Round
- Finland, United States, United Kingdom
Portfolio highlights
- AIATELLA — Automating medical image analysis
- SparkReceipt — AI-powered Receipt Scanner and Expense Tracker for Freelancers and Small Businesses. Get started for free now!
- University of Eastern Finland — The University of Eastern Finland is a multidisciplinary university which offers teaching in more than 100 major subjects. The university comprises four faculties: the Philosophical Faculty, the Faculty of Science and Forestry, the Faculty of Health Sciences, and the Faculty of Social Sciences and Business Studies.
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more
Investment focus
- Software, Manufacturing, Health Care
- Funding Round, Series A, Series B
- Finland, United States, Switzerland
Portfolio highlights
- IQM Quantum Computers — IQM is the leading European quantum hardware company in superconducting circuits. We build quantum computers.
- IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
- DataCrunch.io — DataCrunch is a cloud service provider which facilitates utilization and integration of state of the art AI/ML models
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more
Investment focus
- Software, Health Care, E-Commerce
- Seed, Series A, Funding Round
- Finland, United States, United Kingdom
Portfolio highlights
- Swarmia — Build better software faster with insights that power your whole engineering organization. Get started with a demo or a free 14-day trial.
- Inven — Save time by using AI to find companies. Inven scans millions of websites to provide comprehensive data on companies similar to your search criteria.
- Ovido — Ovido company specialises in supply chain and product data automation, with a focus on providing full product traceability and the establishment of Digital Product Passports (DPPs).
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more
Investment focus
- Biotechnology, Health Care, Artificial Intelligence
- Seed, Pre-Seed, Funding Round
- Finland, Sweden, Norway
Portfolio highlights
- Farang — Farang is an AI research lab based in Sweden developing the next-generation of foundational Large Language Models. The company was founded in 2025 and consists of a team of highly experienced researchers, developers, entrepreneurs and business professionals, joined by prominent deep-tech VCs and angel investors.
- Kuva Space — Kuva Space improves life on Earth through daily, space-borne hyperspectral imaging and AI. We offer Earth observation solutions for more sustainable business.
- MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more
Investment focus
- Health Care, Software, Information Technology
- Seed, Funding Round, Series A
- Finland, United States, Switzerland
Portfolio highlights
- AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
- ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
- Nexstim — Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder.The company was founded in2000 and is headquartered in Helsinki, Southern Finland.
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more
Investment focus
- Health Care, Software, Information Technology
- Seed, Funding Round, Pre-Seed
- Finland, Sweden, Norway
Portfolio highlights
- Atium — Clean water is one of the largest future challenges we stand before, and toxic pollutants are a large contributing factor. Heavy metals are some of the most toxic chemicals to human health and it is our goal, through our innovation, to contribute to a world where water treatment is more environmentally friendly and effective. Atium exists to helpensure clean water, for everyone.
- Reactional Music — Reactional Music is creating a new commercial layer for the global games industry that uses premium, licensed music to drive both user acquisition and player engagement. The company’s technology allows developers and publishers to integrate commercial music at two critical points in the player lifecycle:- Music in User Acquisition – improvingconversion, ROI, and campaign lifespan in playable ads and performance marketing.- Music in Games – increasing retention, session length, and monetization through adaptive, personalized music experiences.Reactional’s platform combines a patented rule-based adaptive music engine, a licensed catalog of more than six million tracks, and an automated rights and royalty system. The technology is already integrated with Unity and Unreal and is deployed across live projects with leading publishers and studios.
- Popit — Popit makes medication connected with a unique, medical grade solution. It tracks medication use automatically and reminds ONLY if you miss. Developed together with healthcare professionals.
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more
Investment focus
- Biotechnology, Health Care, Energy
- Series A, Funding Round, Seed
- Finland
Portfolio highlights
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Pre-Seed, Seed, Series A
- Finland, Estonia, Sweden
Portfolio highlights
- Lutso — Empowering older adults to live independently, safely, and with dignity. Lutso is the smarter way to support aging at home.
- Cytely — Transforms microscopy from image-driven to data-driven through AI-powered autonomous targeting that captures high-resolution data of critical cellular events, enabling researchers to solve complex biological problems in minutes instead of years.
- NROC Security — Prevent data leaks, govern shadow AI, prove compliance, and save 50% on GenAI subscriptions
We fund futurebreakthroughs
Show more
Investment focus
- Apps, Water, Energy
- Seed, Funding Round, Series A
- Finland
Portfolio highlights
- StemSight — StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
- HYPERMINE — Hypermine a novel laser-based mineralogy sensing technology to optimize resource recovery and reduce the negative environmental effects of mining.
- TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more
Investment focus
- Biotechnology, Life Science, Water
- Seed, Series A, Funding Round
- Finland, Sweden, Denmark
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
- Happy Plant Protein — Revolutionize plant protein production with Happy Plant Protein's innovative technology, transforming local ingredients into high-quality, sustainable solutions for the food industry.
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more
Investment focus
- Software, Health Care, Manufacturing
- Seed, Funding Round, Series A
- Finland, Denmark, Sweden
Portfolio highlights
- Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, The Netherlands, Switzerland
Portfolio highlights
- Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
The Climate Fund focuses on combating climate change, boosting low-carbon industry and promoting digitalisation.
Show more
Investment focus
- Energy, Renewable Energy, Sustainability
- Debt Financing, Funding Round, Series A
- Finland
Portfolio highlights
- AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
- Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
- Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- France, United States, United Kingdom
Portfolio highlights
- DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
- AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
- Excelsior Sciences — Rebuilding the World, From the Bottom Up
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Series B
- Finland, Sweden, Denmark
Portfolio highlights
- Klevu — Klevu Oy is a self-learning search engine that helps online retailers turn visitors into customers. Its search for SMEs focuses on fast, relevant search with actionable insights into shoppers’ search and easy self-service integration.Klevu Oy’s enterprise edition provides natural language search with ease of catalog maintenance and insights intoshopping experience. It is based in Helsinki, Southern Finland.
- Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
- Steep — Business intelligence for modern companies. Steep lets anyone on your team stay on top of your data.
VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?
Show more
Investment focus
- Biotechnology, Manufacturing, 3D Technology
- Seed, Funding Round, Series A
- Finland
Portfolio highlights
- Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
- Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
Show more
Investment focus
- Genetics, Hospital, Automotive
- Funding Round
- Finland
Portfolio highlights
- R8tech — R8 Jenny is AI HVAC technology for commercial real estate. It helps you achieve ESG goals while saving up to 30% in energy costs!
- Valmet Automotive — Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of €56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.
Show more
Investment focus
- Health Care, Biotechnology, Therapeutics
- Funding Round, Series A, Series C
- Finland, The Netherlands
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- SET Ventures — SET propels founders from early growth to European scale. We invest in and grow the solutions powering the digital energy economy.
Fazer Group mission is to create taste sensations. Customer orientation, quality and operations are based.
Show more
Investment focus
- Biotechnology, Food Processing
- Series A, Series B, Funding Round
- Finland
Portfolio highlights
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more
Investment focus
- Biotechnology, Health Care, Energy
- Debt Financing, Post-IPO Debt, Funding Round
- Germany, France, The Netherlands
Portfolio highlights
- Amadix — Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide.The most advancedproduct developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients).Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.
- Greenlight Biosciences — Next Generation Crop Protection
- Azienda Comprensoriale Acquedottistica — ACA Spa is an integrated water service company.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Funding Round
- United States, Sweden, France
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more
Investment focus
- Apps, Food Processing, Food and Beverage
- Seed
- Finland
Portfolio highlights
- AIATELLA — Automating medical image analysis
- Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Zhejiang Huahai Pharmaceutical Co. Ltd. is a Phermaceutical Company.
Show more
Investment focus
- Biotechnology, Pharmaceutical, Therapeutics
- Series A
- China, Finland
Portfolio highlights
- Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
- Yannuo Pharmaceutical — Yannuo Pharmaceutical is a high-tech enterprise focusing on the research and development of complex injections. It has three main drug research and development technology platforms: liposomes, nanoparticles, and microspheres. Relying on the advanced drug delivery technology platform, the company adheres to the clinical needs-oriented and conductsresearch and development of small molecule drugs, nucleic acid drugs, peptides, and protein drugs. Deepen development and industrialization, focusing on the tumor, contrast agents, anesthesia and pain, and other therapeutic areas.
Emerald Technology Ventures specializes in clean technology venture capital. Emerald focuses on the areas of energy, water, and materials. , Emerald manages several venture capital funds and venture capital portfolio mandates.
Show more
Investment focus
- Manufacturing, Software, Energy
- Funding Round, Series B, Series A
- United States, Germany, Finland
Portfolio highlights
- Vytal — Start the Packaging Revolution! We are offering smart & reusable To-Go Packaging-as-a-Service to gastronomy clients & consumers.In Germany the consumption of take-away, convenience and delivery food & drinks is responsible for about 281 kilotons of single-use packaging waste for immediate consumption and is growing at double digitrates. Most of the time, To-Go food containers, snack boxes or coffee cups have a very short life-span of only 30 minutes after which they are tossed into trash (or litter parks, beaches & the ocean). This is not only a giant waste of economic resources as each single use costs between 15 and up to 0,60€ for a stable bowl/box with a lid. It is a horrendous waste of environmental resources (wood, water, crude oil, metals & energy) that are used to produce this packaging. Therefore, a single use packaging not weighing more than 30 grams can easily come with an ecological backpack of more than 8 kilograms when taking into account all the resources used in production (material intensities taken from Wuppertal Institute for Climate, Environment and Energy). Looking at GHG emissions, the picture is similarly bleak: Using CO2 emission factors and the detailed material mix of the single-use packaging waste analyzed by NABU (German Nature and Biodiversity Conservation Union), the 281 thousand tons waste from To-Go consumption generated around 556 thousand tons of CO2 or the equivalent of 195k passenger cars per year (assuming an average distance travelled of 15,000km). With the expected rise of take-away, convenience and delivery food, the related emissions are expected to increase at double digit rates as waste volume is expected to increase and as we saw a shift to plastics relative to cardboard or other materials. While there is a growing awareness of the problem, especially in Germany, there is no scalable solution yet and the commonly used alternative of nature-based & ‘biodegradable’ materials like bagasse or PLA also require many resources for production & transport, and have to be incinerated or go to landfill after use as there is currently no way to compost them.
- Xampla — Xampla's natural plant polymer technology is the innovative technology powering materials to change the world with plastic-free replacements and more.
- Waterly — Dramatically simplify your water operations.
Thames Trust
Show more
Investment focus
- SaaS, FinTech, Finance
- Seed, Series A, Series B
- United Kingdom, Finland
Portfolio highlights
- STEM — For makers, learners, and players. Creative computing projects, stories, and more.
- Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
- ABAKA Holdings — ABAKA is world's first digital saving and retirement enterprise SaaS platform, powered by Artificial Intelligence. Our innovative technologies enable financial institutions to power digital saving and retirement solutions and deliver scalable and affordable advice on pensions, savings and investments to their retail customers. ABAKA’s libraryof modular applications helps our enterprise clients to power conversational AI, personalised and behavioural nudges, big data insights, financial dashboards and outstanding customer experiences.Today over 9 million people have access to the ABAKA technologies through our clients, and our technologies are licensed by Tier one international banks, pension providers and asset managers across multiple countries.ABAKA’s enterprise solutions enable financial institutions to power: • Conversational AI: on pensions, savings and investments, for both fully digital and hybrid advice. The proprietary NLP models take vast quantities of user behavioural and financial data to intelligently manage a human like conversation. • Intelligent Behavioural Nudges: machine learning models to identify persona segmentation, power personalised insights and nudges to increase engagement and up-sell opportunities, across digital channels. • Digital financial dashboards: data aggregation technology powering Open Banking, Pension Tracing and Pension Dashboards. • Financial Planning Engine: retirement planning, cash flow modelling, suitability assessment, Monte-Carlo simulations for outcome & scenario driven advice
Valve Ventures is a Helsinki-based angel and early-stage venture investor.
Show more
Investment focus
- Energy, CleanTech, Oil and Gas
- Seed, Series A, Funding Round
- Finland
Portfolio highlights
- Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
- Woodio — Woodio is a digital designing agency.
- Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.
Show more
Investment focus
- Medical Device, Sensor, Medical
- Series A, Series C, Funding Round
- Finland, United States
Portfolio highlights
- Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Illusian is the Founder Office of people who have founded and scaled companies like Supercell, Zalando, Wolt, Aiven, Pigment, and Smartly. While the group is still busy running their businesses, they've aligned their networks, capital, and expertise to simultaneously support the next generation of builders.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Series B
- Finland, United States, Germany
Portfolio highlights
- Ever (evercars.com) — Ever is a technology and automotive company that helps its customers buy and sell high-quality electric vehicles. The company is based out of San Francisco, backed by leading investors, and led by former tech & automotive professionals from Uber, Lithia, Penske, Rivian, Carvana, Tesla, Lucid, TrueCar, Longo Toyota, Boston Consulting Group, J.P.Morgan, Lyft, Shopify, Flexport, Golden Gate Capital, and more.
- IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
- Ovido — Ovido company specialises in supply chain and product data automation, with a focus on providing full product traceability and the establishment of Digital Product Passports (DPPs).
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Seed, Series B
- United States, Canada, Israel
Portfolio highlights
- Aria CV — Learn about Aria CV's novel implantable medical device designed to treat pulmonary hypertension (PH). Our elegant device has no battery, pump, or electronics.
- Alveron Pharma — Alveron produces drugs such as cyclodextrins, pro-coagualant cyclodextrins with a unique coagulation platform technology.
- CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Takoa Invest is a Finnish family-owned investment company that owns and develops companies and properties with growth potential in Finland and abroad. Takoa Invest is a Finnish family-owned investment company. It owns and develops companies and properties with growth potential in Finland and abroad.
Show more
Investment focus
- Biotechnology, Mobile, Retail
- Seed, Series B, Series C
- Finland, Israel
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
- IndoorAtlas — Discover the power of indoor positioning technology with IndoorAtlas. Build innovative indoor location-based solutions using our cross-platform SDK. Explore case studies and start developing today.
Nordea Bank is Denmark's second-largest bank and counts every fourth Dane among its customers. Through their nationwide network of some 340 branch offices and a broad range of self-service facilities, they are able to offer you a full scale of financial products and services, including Netbank, Online Investment, telephone banking and cashdispensers.
Show more
Investment focus
- FinTech, Financial Services, Banking
- Funding Round, Debt Financing, Seed
- Finland, Sweden, Norway
Portfolio highlights
- Tibber — Tibber is a digital electricity supplier that offers smart solutions to minimize their customers’ consumption and costs. Its vision is to make sustainable energy consumption simple and affordable for all households. Tibber's mission is to reduce the residential electricity consumption for European households by 20 %. Founded in Norway andSweden in 2016, the company has expanded its offer to Sweden and Germany where it powers hundreds of thousands of homes. Tibber replaces traditional utilities with smart technology, supplying its customers with renewable energy at fair and transparent prices. In addition, its app provides real-time analytics into energy usage, and pairs with a variety of smart home devices to reduce electricity consumption at home. The company sells tech-gadgets in their online store and recently was licensed to balance the main power grid in Sweden with EVs.
- Statzon — Make data-driven plans & faster decisions with a simple access to +1M datasets & market reports about 8,000 topics from +200 trusted data providers.
- Get It Done Now — GIDN is a Nigerian Fintech Company targeting medium and low income population for Loans and Financial products. GIDN has in addition a cashless, mobile based community marketplace, with more than 5k members, and aims to regulate the informal economy and facilitate the purchase of Services and Digital Products.
The Stockholm Techstars Accelerator invests in early-stage, high-growth companies looking to build and expand in the Nordic-Baltic startup ecosystem.
Show more
Investment focus
- Pet, FinTech, Finance
- Pre-Seed
- Israel, Norway, Sweden
Portfolio highlights
- goscore — Fair human credit scoring, credit check, and assessment for you
- Terrawaste — TerraWaste is a next-generation chemical recycling company that turns non-recyclable waste into value by creating new, climate-positive materials with a pollution-free process. TerraWaste focuses on lowering the level of need for virgin oil extraction by recycling plastics with chemical recycling technology 'htloop' into high-qualityclimate-positive crude oil, biochar, and high-value chemicals to support companies globally to become more sustainable and circular. Our technology (htloop) is developed on a process developed in the laboratory for over 20 years and hasn’t been commercialized until recently. TerraWaste is the first company to use HTL to recycle plastic waste and turn it into new plastic products. The unique thing is the state-of-the-art technological system that will recycle waste in a continuous-flow system, at the same time reusing heat and water in a loop, that way dramatically decreasing energy consumption. Our process is pollution free, and we produce carbon-negative output materials, that way offsetting other, carbon-heavy industries.
- Five Letter Foods — Real food for dogs. Ultra-processed junk food is boring and makes your dog sick. Our meal kits have a full swing of variety. Death to kibble.
Founded in 2016, Wave Ventures is the largest student-run VC in Europe, backed by Nordic unicorn founders, investing in Gen Z entrepreneurs at the earliest stage. We operate both from Finland and Sweden with a team of five people from the top universities in the region.
Show more
Investment focus
- Software, Mobile Apps, Information Technology
- Seed, Pre-Seed, Funding Round
- Finland, Sweden, Germany
Portfolio highlights
- Bought — Everything you've bought, automatically ready for resale.
- Sustashift — Sustashift offers a comprehensive legal CSRD reporting tool, providing tailored audit templates and automated XBRL tagging to streamline compliance and reduce manual reporting efforts.
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
Eqvitec Partners is a privately owned and independent Nordic private equity firm, advising six funds with a total capital base of over €500 million. Equity funds invest in technology companies in all phases from early-stage to buyouts. Mezzanine funds focus on buyouts and expansion financing.Eqvitec Partners offers a combination of experienceand expertise to companies with an attractive business model and solid growth potential. They spend a lot of time with the portfolio companies working closely with the management on a board level. Their aim is to add significant value, particularly via intellectual capital, with a focus on strategy implementation and business development. In addition, they bring a significant network and financial know-how to their portfolio companies. Eqvitec funds typically exit the investments after 3-6 years through a trade sale or a stock exchange floatation.Eqvitec Partners was established in 1997 and currently has 15 employees in the Helsinki and Stockholm offices.They are a member of the Finnish Venture Capital Association (FVCA), Swedish Venture Capital Association (SVCA), European Private Equity and Venture Capital Association (EVCA) and Nordic Venture Network (NVN).
Show more
Investment focus
- Software, Information Technology, Enterprise Software
- Funding Round, Series A, Seed
- Finland, Sweden, United Kingdom
Portfolio highlights
- Norstel — Norstel AB manufactures and develops wide bandgap semiconductor materials, including silicon carbide (SiC) wafers and epitaxial layers.
- eBuilder — eBuilder is a global company that optimizes and automates administrative processes for corporations and public sector agencies through IT-based business process outsourcing.
- MediSapiens — MediSapiens provides software solutions to clients in the biomedical field. Our solutions turn biomedical data into new insights and knowledge. Our clients
We are Valio Group: the most innovative dairy and food company in the world.
Show more
Investment focus
- Life Science, Biotechnology
- Series A, Series B
- Finland
Portfolio highlights
- Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!
Show more
Investment focus
- Health Care, Artificial Intelligence, Medical
- Series A, Series B, Series C
- United States, United Kingdom, Spain
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
Aqua-Spark is an investment fund with a focus on sustainable aquaculture businesses around the world. The small-to-medium enterprises (SMEs) they invest in are working toward the production of safe, accessible aquatic life, such as fish, shellfish and plants, in ways that do not harm their oceans. Their investors value the fact that each investmentaims to create triple impact—specifically, each investment is chosen for its potential to generate significant financial returns while also activating positive environmental and social outcomes.Aqua-Spark believes that committing to a long-term vision is the way to realize effective and lasting impact results. When it comes to investments, they do not seek quick exits; instead, they look for entrepreneurs who strive to build and scale toward the future, who see their business as major economic opportunities that can also help solve looming environmental and food security challenges over the long-term. As an essential of each investee, Aqua-Spark seeks sustainability.
Show more
Investment focus
- Biotechnology, Aquaculture, Seafood
- Funding Round, Series A, Seed
- United States, Norway, Israel
Portfolio highlights
- Protix — Discover how Protix is revolutionizing the food system by converting organic waste into nutritious insect-based ingredients for a sustainable future.
- XpertSea — XpertSea is a Canadian technology company that's transforming how the global aquaculture industry farms seafood to help feed the world. Combining smart aquaculture equipment with a farm management platform, our collaborative solution uncovers actionable insights driven by artificial intelligence. These insights enable farmers and industryexperts to optimize feed efficiency, reduce environmental waste, take preventive actions against diseases and use data to bring transparency and knowledge to the entire supply chain. With customers in over 50 countries, we’re using Canadian ingenuity to make aquaculture profitable and sustainable.
- Proteon Pharmaceuticals — Proteon Pharmaceuticals serves livestock and aquaculture farms that aim for high-quality and sustainable protein production.
Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- United States, United Kingdom, France
Portfolio highlights
- Argá Medtech — Novel Sine Wave Technology Promises Significant Advantages Over Existing Pulsed Field Cardiac Ablation Systems
- PIC Therapeutics — PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
- Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.
The EU framework programme for research and innovation
Show more
Investment focus
- Biotechnology, Health Care, Software
- Grant, Seed, Funding Round
- Spain, Switzerland, United Kingdom
Portfolio highlights
- NovaMea — NovaMea is a cleantech startup that designs and commercializes electrochemical systems for energy storage and conversion.Its purpose is to create technology, services, and products for the storage and conversion of energy using electrochemical processes, as well as to produce, store, sell, and distribute these products and their components.
- Perciv AI — Perciv provides artificial intelligence (AI)-based software solutions to unlock the latent possibilities of radars and allow resilient and economical autonomous systems with Lidar-like performance even in severe weather circumstances.
- Neuron Soundware — Neuron Soundware uses Artificial Intelligence and Machine Learning in combination with the analysis of sound and other physical parameters.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more
Investment focus
- Health Care, Software, Information Technology
- Seed, Funding Round, Series A
- Germany, United Kingdom, Finland
Portfolio highlights
- Elio — Putting leading scientific data into context, to enable others to respond to climate change’s dynamism and act on solutions with confidence.
- Ocean Ledger — Precision analytics to design, implement & monitor coastal mitigation and adaptation.
- NatureMetrics — NatureMetrics is the World-Leading provider of Biodiversity monitoring data, using eDNA surveys, metabarcoding & more. Book your demo today!
H&M Group Ventures is the venture capital arm of the H&M Group.
Show more
Investment focus
- E-Commerce, Fashion, Textiles
- Funding Round, Series A, Series B
- Sweden, United States, United Kingdom
Portfolio highlights
- Centra — Centra is part of creating the next generation of brands, with a direct-to-consumer and wholesale e-commerce software for global brands. Brands across Scandinavia and the world trust Centra to seamlessly connect people to products. We're a medium-sized company with offices in Stockholm, Sweden, Wroclaw, Poland and New York City, USA.
- Voyado — All-in-one CRM, Loyalty, CDP, marketing software and AI-powered product discovery purely built for retail and e-commerce.
- Colorifix — Colorifix is a biotechnology company that has pioneered the first entirely biological process to produce, deposit and fix pigments onto textiles. Using a synthetic biology approach, it offers a radically different solution to incumbent dyeing technologies that entirely cuts out the use of harsh chemistry and leads to huge reductions in waterconsumption. Colorifix’s investors include Cambridge Enterprise, H&M, Mills Fabrica, Primera Impact and Sagana, whose collective backing is funding its expansion. For more information, visit www.colorifix.com
Keksintösäätiö
Show more
Investment focus
- Apps, Health Care, Biotechnology
- Seed
- Finland
Portfolio highlights
- TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
WE HELP YOU TO GROW FASTER!
Show more
Investment focus
- Software, Information Technology, Internet
- Seed, Funding Round, Series A
- Finland, United States, United Kingdom
Portfolio highlights
- Pebble — Pebble is a electric vehicle manufacturing startup.
- Transfluent — Professional translations for all business needs. Fast. Easy.
- BetterDoctor — Our provider network software solutions & services provide unmatched tools & insights for you. Discover how you can measure, manage, monitor & model.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series A, Series C
- United States, Switzerland, United Kingdom
Portfolio highlights
- Citryll — Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and other human diseases. The company offers formation, function, and clearance of NETs downstream of the protein citrullination pathway catalyzed by Peptidylarginine Deiminase (PAD) enzymes that enable doctors to help in the treatment of lupus,vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis.Citryll was established in 2015 and is headquartered in Oss, The Netherlands.
- Rhygaze — Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
- Alesta Therapeutics — Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic approaches to treat cancer
Tekes Venture Capital invests in companies in their early stages of development. Its purpose is to develop Finland's venture capital market.
Show more
Investment focus
- Genetics, Hospital, Health Care
- Funding Round
- Finland
Portfolio highlights
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Unifund Jyväskylä Ltd is to support the start-up of research-based businesses.
Show more
Investment focus
- Software, Collaboration, Management Consulting
- Funding Round
- Finland
Portfolio highlights
- Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
- PrecisionPhage — PrecisionPhage is a biotech business that specializes on bacteriophage technologies.
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Series A, Funding Round
- Germany, Switzerland, United States
Portfolio highlights
- BTRY — BTRY is a spin-off of EMPA and ETH and is developing the industry's first energy-dense solid-state battery, using sophisticated semiconductor manufacturing technologies.
- Zeeg — Create a customized landing page in just a few clicks and let your customers easily book appointments with you.
- viboo — viboo offers self-learning predictive control on the basis of physics-informed Machine Learning as a cloud service to smart-thermostat and building automation companies.
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Pre-Seed, Series A
- Finland
Portfolio highlights
- Gosta Labs — Focus on care
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Nightingale Health — The most advanced health check for the health industry.
Athensmed Oy
Show more
Investment focus
- Health Care, Medical, mHealth
- Seed, Series A, Funding Round
- Finland
Portfolio highlights
- VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Backing category-defining companies from inception to IPO.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Pre-Seed
- United States, United Kingdom, Brazil
Portfolio highlights
- E-Pal — E-Pal connects high-caliber gamers worldwide, offering you supportive gaming companions anytime, anywhere. You'll never battle alone!
- Lightning AI — Seamlessly train hundreds of Machine Learning models on the cloud from your laptop
- Hauler Hero — Hauler Hero is a waste management software solution that helps waste haulers improve their operations, increase efficiency, and reduce costs.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Sustainability
Venture Capital
Clean Energy
Web3
Organic Food
Art
Big Data
Wellness
Video Games
Android
Digital Media
Publishing
Manufacturing
Construction
B2B
Sports
Franchise
Food and Beverage
eSports
Mobile
Payments
Enterprise Software
Music
Email
Social Media
Real Estate
Social Network
Medical
Finance
Legal
Local
Education
Internet
Biotechnology
Travel
Fitness
Recruiting
Hospitality
Financial Services
Mobile Advertising
Platforms
Cannabis
Automotive
Retail
Social
Wine And Spirits
Medical Device
Infrastructure
Crowdfunding
CleanTech
Mobile Apps
Beauty
Transportation
InsurTech
Photography
Enterprise
Non Profit
LGBT
Oil and Gas
Fashion
Film
Life Science
Theatre
SaaS
Renewable Energy
Sporting Goods
Software
Restaurants
Social Impact
Celebrity
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Singapore
Spain
China
Ghana
Armenia
Egypt
Belarus
Hungary
Saudi Arabia
Finland
France
Croatia
Gibraltar
Barbados
Oceania
Georgia
Greece
Czech Republic
Faroe Islands
Costa Rica
Africa
Hong Kong
Bahrain
Belgium
Denmark
LATAM
Bermuda
Estonia
Algeria
Ecuador
Bulgaria
Asia
Belize
Chile
Ethiopia
Liechtenstein
Panama
Myanmar
Lithuania
Malaysia
Brazil
Peru
Liberia
Jersey
Lebanon
Norway
Mexico
Italy
Mali
Philippines
Togo
Rwanda
Israel
Kuwait
Mauritius
Slovenia
Malta
Morocco
Poland
Nicaragua
Dominican Republic
Uganda
Bahamas
Iraq
Iceland
San Marino
Sweden
Azerbaijan
Nigeria
Serbia
Namibia
United Arab Emirates
Sierra Leone
Thailand
Jamaica
Honduras
Tanzania
Isle of Man
Bolivia
Uzbekistan
Luxembourg
Zambia
Turkey
Pakistan
Albania
Uruguay
Romania
Tajikistan
Russian Federation
Jordan
Grenada
Argentina
Bangladesh
Portugal
El Salvador
Puerto Rico
Senegal
Zimbabwe
Tunisia
Venezuela
Ukraine
Taiwan
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Colombia
Cameroon
Austria
Switzerland
Guatemala
Seychelles
Marshall Islands
VC (Venture Capital) Funds in Finland by industry
Oil and Gas
Restaurants
Sustainability
Transportation
Clean Energy
Financial Services
Big Data
Finance
Food and Beverage
Payments
Sports
Medical Device
Wellness
Social Media
Recruiting
Internet
Social Network
Manufacturing
Digital Media
Mobile
Blockchain
Franchise
Construction
Software
Enterprise Software
Cryptocurrency
Automotive
EdTech
Fitness
Biotechnology
Travel
Enterprise
Platforms
Consumer
Health Care
Biotech
Climate
SaaS
Energy
Impact
Proptech
Marketplace
Community
Artificial intelligence
Hardware
Gaming
Mobile Apps
Retail
Web3
Fashion
Music
B2B
Real Estate
Android
Video Games
FinTech
Medical
Education
Life Science
Media (entertainment)
Agriculture (agtech)
CleanTech
Machine Learning
Hospitality
Renewable Energy
Infrastructure